Home » Newsletters » BioWorld Science

BioWorld Science

June 2, 1997

View Archived Issues

Positive preclinical results for Inflazyme's Apanol

Protein Sciences' influenza vaccine covered under U.S. patent

Vion antiinfective covered under U.S. patent

T Cell Sciences completes patient enrollment for reperfusion injury trial

FDA advisory committee review of EchoGen postponed

Lilly and Megabios enter gene-based therapeutics collaboration

Xenova and Warner-Lambert enter further drug discovery collaboration

Wyeth-Ayerst's Normiflo approved for prevention of deep vein thrombosis

AMBI reports positive results for Cardia Salt Alternative

HIV drug resistance test launched by Murex

MS&D prepares CCK-B/gastrin receptor antagonists

Cephems active against MRSA reported by Bristol-Myers Squibb

Ion channel-forming peptides from Magainin

Mallinckrodt describes new imaging agents

Merck & Co. discloses pneumococcal vaccines

Antimigraine agents from Janssen

Lilly describes agents for Alzheimer's disease

Antiallergic/antiasthmatic agents from Sumitomo Metal

Company Profile: AntiVirals

Astra shifts focus to newer thrombin inhibitor

BTI-322 preclinical and clinical data disclosed at transplant meeting

Anti-LFA-1 MAbs for transplantation

Leflunomide preclinical results presented at transplant congress

Agouron reports structure-based design of calcineurin inhibitors

New NSAID under development in Russia

Molecular structure of prostaglandins responsible for HSF1 activation elucidated

Cardioprotective effects of K-7259 in rat hearts

New i.v. formulation of amiodarone better tolerated in patients

Clinical electrophysiological and hemodynamic effects of BRL-32872A

Mechanism of antiarrhythmic effect of UK-14304

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 12, 2025.
Deep Apple signs big Novo deal for cardiometabolic small molecules
BioWorld
Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an...
23andme genetic privacy concerns garner Congressional scrutiny
BioWorld MedTech
The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate hearing highlighted an interest in...
3Sbio revs on with phase II data in tight PD-1/VEGF bispecific race
BioWorld
3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert...